CorMedix CRMD Preferred Stock Liquidation Preference Value
Preferred Stock Liquidation Preference Value at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockLiquidationPreferenceValue.
The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's preferred stock liquidation preference value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's preferred stock liquidation preference value?
- CorMedix (CRMD) reported preferred stock liquidation preference value of $5.64M in Q1 2026.
- How has CorMedix's preferred stock liquidation preference value changed year-over-year?
- CorMedix's preferred stock liquidation preference value increased by 27.4% year-over-year, from $4.43M to $5.64M.
- What is the long-term trend for CorMedix's preferred stock liquidation preference value?
- Over 5 years (2020 to 2025), CorMedix's preferred stock liquidation preference value has grown at a -95.3% compound annual growth rate (CAGR), from $23.67T to $5.64M.
- What does preferred stock liquidation preference value mean?
- This represents the aggregate amount that preferred shareholders are entitled to receive in the event of a company liquidation, dissolution, or winding up. It highlights the seniority of preferred equity over common equity in the capital structure. Investors monitor this to understand the priority of claims and potential impact on common shareholder value.